ESC 365 - Is sidenafil treatment associated with higher rate of vasoplegia after heart transplantation?

ESC Premium Access

Is sidenafil treatment associated with higher rate of vasoplegia after heart transplantation?

Session: Poster session 4 - Chronic heart failure (CHF)

Topic: Medical aspects of transplantation

Speaker: Mr E. Sole Gonzalez (Barcelona, ES)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Mr Eduard Sole Gonzalez

Hospital Clinic, University of Barcelona, Barcelona (Spain)

0 follower

28 more presentations in this session

Myocardial perfusion in diabetic patients with acute myocardial infarction and long term risk of heart failure development

Speaker: Doctor A. Tomasik (Zabrze, PL)

In vivo evidence of chronic myocardial inflammation in ischaemic cardiomyopathy using USPIO enhanced cardiovascular magnetic resonance

Speaker: Doctor J. Lagan (Chester, GB)

Pattern of myocardial 99mTc-HMDP uptake and impact on myocardial function in patients with transthyretin amyloidosis

Speaker: Miss S. Brun (Toulouse, FR)

Aldehyde dehydrogenase 2 ameliorates cyclophosphamide-induced cardiotoxicity through detoxification of toxic aldehydes and suppression of cell death

Speaker: Doctor J. Wang (Jinan, CN)

A new echo-Doppler index to predict early myocardial toxicity secondary to chemotheraphy

Speaker: Assistant Professor S. Baratta (Pilar, AR)

Access the full session

Poster session 4 - Chronic heart failure (CHF)

Speakers: Mr E. Sole Gonzalez, Doctor A. Tomasik, Doctor J. Lagan, Miss S. Brun, Doctor J. Wang...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources